Compliance, adherence, persistence – causes and consequences of non-adherence to medical recommendations
Journal Title: OncoReview - Year 2012, Vol 2, Issue 1
Abstract
Patients’ non-adherence is among the most serious health problems of mankind. It was recognized as one of the major barriers to achieving benefits from therapies based on current medical knowledge. The aim of this paper is to present basic information about the terminology describing the extent to which the patient follows therapeutic instructions and to outline the scale of the phenomenon and the essence of non-adherence. This paper also describes the causes and consequences of non-adherence. Adherence to therapy with proven clinical efficacy is the primary determinant in achieving the benefits of treatment. Unfortunately the problem of non-adherence is not a priority within scientific interests in Poland. This is reflected in fact that 35% of patients in Poland do not adhere to the recommended therapy. Non-adherence to long-term therapy for chronic illnesses in developed countries averages 50%. Non-compliance to medical recommendations is a multidisciplinary problem. No one has yet discovered a simple panacea that would eliminate this problem. Nowadays it seems to be important to raise awareness regarding the adherence crisis and refine the methods of improving adherence.
Authors and Affiliations
Karolina Skóra
Predicting heart attack in a patient post-radiation therapy using plaque CCTA analysis and serum biomarker test. Case report
Accelerated coronary artery disease (CAD) is a long term manifestation of chest irradiation that may progress to acute myocardial infarction (MI). We report the use of an algorithm-based biomarker test and coronary compu...
Znaczenie inhibitorów aromatazy w leczeniu chorych na raka piersi
Leczenie hormonalne raka piersi ma na celu ograniczenie oddziaływania endogennych estrogenów na komórki nowotworu. Odkrycie receptorów hormonalnych i poznanie ich znaczenia umożliwiło zastosowanie hormonoterapii w celowa...
Steroid-induced diabetes in oncology
Patients with neoplasms belong to the group of higher risk for developing steroid-induced diabetes. The rules of diagnosis of this form of diabetes do not differ from others of its type, but the course and treatment diff...
Cardio-oncology: What is the future?
Perikardiocenteza i aspekty terapii doosierdziowej u chorych onkologicznych - opis przypadku
Przebieg procesu nowotworowego z towarzyszącym wysiękiem płynu do worka osierdziowego ma zmienną dynamikę, a obraz kliniczny i nasilenie objawów związane są bezpośrednio ze stopniem zaburzeń hemodynamicznych i szybkością...